搜索临床试验以:奥法木单抗 1000 毫克
总计1915个结果
-
Shanghai Greenvalley Pharmaceutical Co., Ltd.Shanghai Mental Health Center完全的
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; European Organisation for Research and Treatment...完全的
-
Haukeland University HospitalHaraldsplass Deaconess Hospital招聘中
-
Fundación Pública Andaluza para la gestión de la...完全的
-
Michael SavonaIncyte Corporation; Astex Pharmaceuticals, Inc.; Theradex招聘中
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKline; Millennium Pharmaceuticals, Inc.终止复发性成人弥漫性大细胞淋巴瘤 | 复发性 1 级滤泡性淋巴瘤 | 复发性 2 级滤泡性淋巴瘤 | 复发性 3 级滤泡性淋巴瘤 | 复发性套细胞淋巴瘤美国
-
Jiangsu HengRui Medicine Co., Ltd.未知
-
Novartis Pharmaceuticals招聘中
-
Universitair Ziekenhuis BrusselMerck Serono International SA未知
-
Madhu Chhanda ChoudharyNational Institute of Allergy and Infectious Diseases (NIAID)招聘中
-
National Cancer Centre, SingaporeGlaxoSmithKline完全的
-
Ifakara Health InstituteUniversity of Oxford尚未招聘
-
GlaxoSmithKline完全的
-
Gerald Maguire, MDUniversity of California Riverisde School of Medicine未知
-
Mid and South Essex NHS Foundation TrustUniversity of East Anglia; National Institute for Health Research, United Kingdom; Anglia Ruskin... 和其他合作者完全的
-
Rambam Health Care Campus完全的
-
NantCell, Inc.终止肉瘤 | 大肠癌 | 胰腺癌 | 卵巢癌 | 非小细胞肺癌 | 转移癌 | 实体瘤 | 本地先进
-
Jiangsu Province Hospital of Traditional Chinese...Ministry of Science and Technology of the People´s Republic of China; The First Affiliated Hospital... 和其他合作者未知高血压 | 肾损伤
-
Technische Universität DresdenUniversity Hospital Schleswig-Holstein; University Hospital of Cologne; University Hospital Ulm; University Hospital Dresden完全的
-
Khyber Medical University Peshawar完全的
-
Whanin Pharmaceutical Company完全的
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.Ltd未知
-
OSI PharmaceuticalsCanadian Cancer Trials Group完全的胰腺癌美国, 加拿大, 澳大利亚, 以色列, 新加坡, 英国, 德国, 比利时, 罗马尼亚, 波兰, 阿根廷, 巴西, 智利, 希腊, 意大利, 墨西哥, 新西兰
-
Singapore General HospitalDuke-NUS Graduate Medical School; 60 Degrees Pharmaceuticals LLC撤销
-
Washington University School of MedicineUnited States Department of Defense; University of Texas; Gateway Biotechnology, Inc.终止